pLenti6/V5 Directional TOPO™ Cloning Kit
Product Image
Invitrogen™

pLenti6/V5 Directional TOPO™ Cloning Kit

El kit de clonación pLenti6⁄V5 Directional TOPO™ contiene el vector de expresión lentiviral ViraPower™ adaptado a TOPO™, pLenti6⁄V5-D-TOPO™ para laMás información
Have Questions?
Número de catálogoCantidad
K49551020 reacciones
Número de catálogo K495510
Precio (CLP)
-
Cantidad:
20 reacciones
El kit de clonación pLenti6⁄V5 Directional TOPO™ contiene el vector de expresión lentiviral ViraPower™ adaptado a TOPO™, pLenti6⁄V5-D-TOPO™ para la clonación rápida basada en PCR y la expresión de alto nivel de un gen objetivo en células de mamíferos que se dividen y que no se dividen.El vector incluye el promotor CMV para dirigir la expresión constitutiva de alto nivel del gen objetivo y el marcador de selección de la blasticidina para una selección estable en células de mamíferos.

Ventajas
• Alta eficacia y clonación rápida
• Expresión constitutiva del gen en células de mamíferos in vitro o in vivo que se dividen y no se dividen
• Produce un virus incompetente para la replicación con el fin de mejorar la seguridad biológica del sistema

Características clave
• Sitio de clonación Directional TOPO™ para una clonación direccional rápida y eficaz de productos de PCR de extremos romos
• Potenciador⁄promotor del virus del sarcoma de Rous (RSV) para la producción de ARNm viral independiente de Tat en la línea celular del productor
• Repeticiones terminales largas (LTR) y VIH-1 5’ y 3’ modificados para envasado viral y transcripción inversa
• Secuencia de envasado para el VIH-1 psi (ψ) para el envasado viral
• Elemento de respuesta Rev VIH (RRE) para la exportación nuclear dependiente de Rev de ARNm viral sin empalmar
• Promotor inmediato-precoz (CMV) de la expresión constitutiva de alto nivel del gen de interés en las células de mamíferos
• Epítopo C-terminal V5 para la detección de proteínas recombinantes
• Gen de resistencia a la blasticidina (bsd) para la selección en E. coli y células de mamíferos
• Gen de resistencia a la ampicilina para una sólida selección en E. coli
• Origen de pUC para una alta replicación de copias y el mantenimiento del plásmido en E. coli

El kit incluye:
Reactivos pLenti6⁄V5-D-TOPO™
E. coli One Shot™ Stbl3™ químicamente competente

Para uso exclusivo en investigación.No está previsto para ningún uso terapéutico o de diagnóstico.
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Método de clonaciónTOPO™ direccional
Sistema constitutivo o inducibleConstitutivo
Tipo de entregaLentiviral
Para utilizar con (aplicación)Expresión viral
N.º de reacciones20 reactions
Línea de productosTOPO, ViraPower
Tipo de productoKit de clonación TOPO
PromotorCMV
Etiqueta de proteínaEtiqueta de epítopo V5
Cantidad20 reacciones
Agente de selección (eucariótico)Blasticidina
VectorpLenti, vectores TOPO direccionales
Unit SizeEach
Contenido y almacenamiento
Reactivos pLenti⁄V5-D-TOPO™ (caja 1). Almacenar a -20 °C
• Reactivos pLenti6⁄V5-D-TOPO™ (15-20 ng ⁄µ de ADN plasmídico linealizado en: 50 % de glicerol, 50 mM Tris-HCl, pH 7,4 (a 25°C),1 mM EDTA, 2 mM DTT, 0,1 % Triton X-100, 100 µ⁄gml BSA, 30 µM azul de bromofenol)
• mezcla de dNTP (12,5 mM cada dATP, dCTP, dGTP, dTTP en agua, pH8 a un volumen total de 10 µl)
• solución de sal (1,2 M de NaCl y 0,06 M de MgCl2, volumen de 50 µl)
• Agua (1 ml)
• Primer de secuenciación de avance CMV (0,1 µ⁄µl en tampón TE, pH 8, pH8 a un volumen total de 20 µl)
• cebadores de PCR de control (0,1 µ⁄µl cada uno en tampón TE, pH 8, PH8 a un volumen total de 10 µl)
• plantilla de PCR de control (0,1 µ⁄µl en tampón TE, pH 8, pH8 a un volumen total de 10 µl)
• plenti6⁄V5-G⁄WlacZ (liofilizado en tampón TE, pH 8, 10 µg)

E.™™ coli químicamente competente en un disparo Stbl3 (recuadro 2) Almacenar a -80 °C
• medio SOC 2 % de triptona, 0,5 % de extracto de levadura, 10 mM de NaCl, 2,5 mM de KCl, 10 mM de MgCl2, 10 mM de MgSO4, 20 mM de glucosa. 6 ml) Puede almacenarse a +4 °C o a temperatura ambiente
•™ Celdas Stbl3 (21 x 50 µl)
• pUC19 ADN de control (10 p⁄µgl en 5 mM Tris-HCl, 0,5 mM EDTA, pH 8. 50 µl)

Preguntas frecuentes

I performed stable selection but my antibiotic-resistant clones do not express my gene of interest. What could have gone wrong?

Here are possible causes and solutions:

Detection method may not be appropriate or sensitive enough:
- We recommend optimizing the detection protocol or finding more sensitive methods. If the protein is being detected by Coomassie/silver staining, we recommend doing a western blot for increased sensitivity. The presence of endogenous proteins in the lysate may obscure the protein of interest in a Coomassie/silver stain. If available, we recommend using a positive control for the western blot.
- Insufficient number of clones screened: Screen at least 20 clones.
- Inappropriate antibiotic concentration used for stable selection: Make sure the antibiotic kill curve was performed correctly. Since the potency of a given antibiotic depends upon cell type, serum, medium, and culture technique, the dose must be determined each time a stable selection is performed. Even the stable cell lines we offer may be more or less sensitive to the dose we recommend if the medium or serum is significantly different.
- Expression of gene product (even low level) may not be compatible with growth of the cell line: Use an inducible expression system.
- Negative clones may result from preferential linearization at a vector site critical for expression of the gene of interest: Linearize the vector at a site that is not critical for expression, such as within the bacterial resistance marker.

I used a mammalian expression vector but do not get any expression of my protein. Can you help me troubleshoot?

Here are possible causes and solutions:

- Try the control expression that is included in the kit
Possible detection problem:

- Detection of expressed protein may not be possible in a transient transfection, since the transfection efficiency may be too low for detection by methods that assess the entire transfected population. We recommend optimizing the transfection efficiency, doing stable selection, or using methods that permit examination of individual cells. You can also increase the level of expression by changing the promoter or cell type.
- Expression within the cell may be too low for the chosen detection method. We recommend optimizing the detection protocol or finding more sensitive methods. If the protein is being detected by Coomassie/silver staining, we recommend doing a western blot for increased sensitivity. The presence of endogenous proteins in the lysate may obscure the protein of interest in a Coomassie/silver stain. If available, we recommend using a positive control for the western blot. Protein might be degraded or truncated: Check on a Northern. Possible time-course issue: Since the expression of a protein over time will depend upon the nature of the protein, we always recommend doing a time course for expression. A pilot time-course assay will help to determine the optimal window for expression. Possible cloning issues: Verify clones by restriction digestion and/or sequencing.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I am using a mammalian expression vector that has the neomycin resistance gene. Can I use neomycin for stable selection in mammalian cells?

No; neomycin is toxic to mammalian cells. We recommend using Geneticin (a.k.a. G418 Sulfate), as it is a less toxic and very effective alternative for selection in mammalian cells.

Is it okay if my construct has an ATG that is upstream of the ATG in my gene of interest? Will it interfere with translation of my gene?

Translation initiation will occur at the first ATG encountered by the ribosome, although in the absence of a Kozak sequence, initiation will be relatively weak. Any insert downstream would express a fusion protein if it is in frame with this initial ATG, but levels of expressed protein are predicted to be low if there is a non-Kozak consensus sequence. If the vector contains a non-Kozak consensus ATG, we recommend that you clone your gene upstream of that ATG and include a Kozak sequence for optimal expression.

Do you offer a GFP-expressing mammalian expression vector that I can use as a control to monitor my transfection and expression?

We offer pJTI R4 Exp CMV EmGFP pA Vector, Cat. No. A14146, which you can use to monitor your transfection and expression.

Citations & References (2)

Citations & References
Abstract
RIP140-targeted repression of gene expression in adipocytes.
Authors:Christian M, Kiskinis E, Debevec D, Leonardsson G, White R, Parker MG,
Journal:Mol Cell Biol
PubMed ID:16227589
'Ligand-dependent repression of nuclear receptor activity forms a novel mechanism for regulating gene expression. To investigate the intrinsic role of the corepressor RIP140, we have monitored gene expression profiles in cells that express or lack the RIP140 gene and that can be induced to undergo adipogenesis in vitro. In contrast ... More
Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3.
Authors:Saunders WB, Bohnsack BL, Faske JB, Anthis NJ, Bayless KJ, Hirschi KK, Davis GE,
Journal:J Cell Biol
PubMed ID:17030988
The endothelial cell (EC)-derived tissue inhibitor of metalloproteinase-2 (TIMP-2) and pericyte-derived TIMP-3 are shown to coregulate human capillary tube stabilization following EC-pericyte interactions through a combined ability to block EC tube morphogenesis and regression in three-dimensional collagen matrices. EC-pericyte interactions strongly induce TIMP-3 expression by pericytes, whereas ECs produce TIMP-2 ... More